S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 17, 2013, Pages 2372-2382

  Zhang, J ^a   Zhang, D L ^a   Jiao, X L ^a   Dong, Q ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; MMP 9; Nuclear factor kappa B; S100A4

Indexed keywords

BATIMASTAT; CALVASCULIN; CARISOPRODOL; COMPLEMENTARY DNA; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC METASTASIS; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR PORTAL VEIN INVASION; METASTASIS; METASTASIS POTENTIAL; MICROVASCULAR INVASION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PHENYLALANINE; PYRROLIDINES; RNA, SMALL INTERFERING; S100 PROTEINS; THIOCARBAMATES; THIOPHENES; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84884245450     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. GOYAL L, MUZUMDAR MD, ZHU AX. Targeting the HGF/c-MET pathway in hepatocellular carcinoma. Clin Cancer Res 2013; 19: 2310-2318.
2. AMBARTSUMIAN N, TARABYKINA S, GRIGORIAN M, TULCHINSKY E, HULGAARD E, GEORGIEV G, LUKANIDIN E. Characterization of two splice variants of metastasis-associated human mts1 gene. Gene 1995; 159: 125-130.
3. MARENHOLZ I, HEIZMANN CW, FRITZ G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004; 322: 1111-1122.
4. SALEEM M, KWEON MH, JOHNSON JJ, ADHAMI VM, ELCHEVA I, KHAN N, BIN HAFEEZ B, BHAT KM, SARFARAZ S, REAGAN-SHAW S, SPIEGELMAN VS, SETALURI V, MUKHTAR H.S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A 2006; 103: 14825-14830.
5. HELFMAN DM, KIM EJ, LUKANIDIN E, GRIGORIAN M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005; 92: 1955-1988.
6. DAVIES BR, DAVIES MP, GIBBS FE, BARRACLOUGH R, RUDLAND PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calciumbinding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008.
7. GRIGORIAN M, AMBARTSUMIAN N, LYKKESFELDT AE, BASTHOLM L, ELLING F, GEORGIEV G, LUKANIDIN E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 1996; 67: 831-841.
8. MAELANDSMO GM, HOVIG E, SKREDE M, ENGEBRAATEN O, FLORENES VA, MYKLEBOST O, GRIGORIAN M, LUKANIDIN E, SCANLON KJ, FODSTAD O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490-5498.
9. TAKENAGA K, NAKAMURA Y, SAKIYAMA S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997; 14: 331-337.
10. RUDLAND PS, PLATT-HIGGINS A, RENSHAW C, WEST CR, WINSTANLEY JH, ROBERTSON L, BARRACLOUGH R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60: 1595-1603.
11. MAZZUCCHELLI L. Protein S100A4: too long overlooked by pathologists? Am J Pathol 2002; 160: 7-13.
12. LIU Z, LIU H, PAN H, DU Q, LIANG J. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. J Int Med Res 2013; 41: 457-462.
13. BJØRNLAND K, WINBERG JO, ODEGAARD OT, HOVIG E, LOENNECHEN T, AASEN AO, FODSTAD O, MAELANDSMO GM. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702-4708.
14. CHEN D, ZHENG XF, YANG ZY, LIU DX, ZHANG GY, JIAO XL, ZHAO H. S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells. World J Gastroenterol 2012; 18: 915-922.
15. ZHANG K, ZHANG M, ZHAO H, YAN B, ZHANG D, LIANG J. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Dis Esophagus 2012; 25: 731-739.
16. CAO WH, LIU HM, LIU X, LI JG, LIANG J, LIU M, NIU ZH. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling. Eur Rev Med Pharmacol Sci 2013; 17: 609-617.
17. YANG XC, WANG X, LUO L, DONG DH, YU QC, WANG XS, ZHAO K. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-κB dependent MMP-2 and bcl-2 pathway. Eur Rev Med Pharmacol Sci 2013; 17: 1669-1680.
18. JIA W, GAO XJ, ZHANG ZD, YANG ZX, ZHANG G. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur Rev Med Pharmacol Sci 2013; 17: 1495-508.
19. YEH MH, KAO ST, HUNG CM, LIU CJ, LEE KH, YEH CC. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol Lett 2009; 184: 204-210.
20. YU HB, ZHANG HF, LI DY, ZHANG X, XUE HZ, ZHAO SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res 2011; 13: 242-250.
21. HSIEH HL, SCHAFER BW, WEIGLE B, HEIZMANN CW. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun 2004; 316: 949-959.
22. YAMMANI RR, CARLSON CS, BRESNICK AR, LOESER RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006; 54: 2901-2911.
23. BOYE K, GROTTEROD I, AASHEIM HC, HOVIG E, MAELANDSMO GM. Activation of NF-κB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes. Int J Cancer 2008; 123: 1301-1310.
24. HOSHIDA Y, VILLANUEVA A, KOBAYASHI M. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004.
25. ZABLE U, HENKEL T, SILVA MDS, BACUERLE P. Nuclear uptake control of NF-κB by MAD-3, an IkB protein in the nucleus. EMBO J 1993; 12: 201-211.
26. YANG P, YUAN W, HE J, WANG J, YU L, JIN X, HU Y, LIAO M, CHEN Z, ZHANG Y. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis. Hepatol Res 2009; 39: 1169-1177.
27. PEDERSEN KB, NESLAND JM, FODSTAD Ø, MAELANDSMO GM. Expression of S100A4, E-cadherin, alphaand beta-catenin in breast cancer biopsies. Br J Cancer 2002; 87: 1281-1286.
28. ROSTY C, UEKI T, ARGANI P, JANSEN M, YEO CJ, CAMERON JL, HRUBAN RH, GOGGINS M. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002; 160: 45-50.
29. NINOMIYA I, OHTA T, FUSHIDA S, ENDO Y, HASHIMOTO T, YAGI M, FUJIMURA T, NISHIMURA G, TANI T, SHIMIZU K, YONEMURA Y, HEIZMANN CW, SCHÄFER BW, SASAKI T, MIWA K. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol 2001; 18: 715-720.
30. MIN HS, CHOE G, KIM SW, PARK YJ, PARK DO J, YOUN YK, PARK SH, CHO BY, PARK SY. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol 2008; 21: 748-755.
31. ALGUL H, ADLER G, SCHMID RM. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer. Int J Gastrointest Cancer 2002; 31: 71-78.
32. ARLT A, GEHRZ A, MUERKOSTER S, VORNDAMM J, KRUSE ML, FOLSCH UR, SCHAFER H. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabineinduced cell death. Oncogene 2003; 22: 3243-3251.
33. MUERKOSTER S, ARLT A, WITT M, GEHRZ A, HAYE S, MARCH C, GROHMANN F, WEGEHENKEL K, KALTHOFF H, FOLSCH UR, SCHAFER H. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer 2003; 104: 469-476.
34. SCLABAS GM, FUJIOKA S, SCHMIDT C, EVANS DB, CHIAO PJ. NFkappaB in pancreatic cancer. Int J Gastrointest Cancer 2003; 33: 15-26.
35. GROTTERØD I, MAELANDSMO GM, BOYE K. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NFkappaB. BMC Cancer 2010; 10: 241.
36. HUA J, CHEN D, FU H, ZHANG R, SHEN W, LIU S, SUN K, SUN X. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo. Cancer Lett 2010; 292: 41-47.
37. RICCA A, BIROCCIO A, DEL BUFALO D, MACKAY AR, SANTONI A, CIPPITELLI M. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7 (ADR) breast-cancer cells. Int J Cancer 2000; 86: 188-196.
38. YAN C, WANG H, BOYD DD. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem 2001; 276: 1164-1172.
39. HARIMAYA K, TANAKA K, MATSUMOTO Y, SATO H, MATSUDA S, IWAMOTO Y. Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NF-kappaB activation. Clin Exp Metastasis 2000; 18: 121-129.
40. HUANG S, PETTAWAY CA, UEHARA H, BUCANA CD, FIDLER IJ. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001; 20: 4188-4197.
41. SATO H, SEIKI M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
42. HE C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 1996; 106: 185-191.
43. ZHANG G, LI M, JIN J, BAI Y, YANG C. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Asian Pac J Cancer Prev 2011; 12: 2075-2080.